Richard Bedlack

7.2k citations

101 papers · 2.8k indexed · h-index 28

Impact in

Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
- Myasthenia Gravis and Thymoma
- Neuroinflammation and Neurodegeneration Mechanisms
Genetics top 1%
- Neurogenetic and Muscular Disorders Research

Papers in

Neurology 83
- Amyotrophic Lateral Sclerosis Research 72
- Parkinson's Disease Mechanisms and Treatments 21
- Myasthenia Gravis and Thymoma 6
- Peripheral Neuropathies and Disorders 5
Genetics 39
- Neurogenetic and Muscular Disorders Research 39

Co-authors: Leslie M. Loew E. Gross Donald B. Sanders Meiting Wei Dan H. Moore Merit Cudkowicz Joel C. Morgenlander Daniel M. Pastula
Journals: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (24 papers)Neurology (11 papers)Muscle & Nerve (7 papers)Cochrane Database of Systematic Reviews (2 papers)Neuron (2 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Richard Bedlack

94 papers receiving 2.7k citations

Peers

Countries citing papers authored by Richard Bedlack

Since Specialization

Citations

This map shows the geographic impact of Richard Bedlack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bedlack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bedlack more than expected).

Fields of papers citing papers by Richard Bedlack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Bedlack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bedlack. The network helps show where Richard Bedlack may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard Bedlack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Bedlack Line = papers co-authored together Richard Bedlack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Worsening Problem in ALS: Insurance Barriers Between Drug Approvals and Patient Access LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) ·Richard Bedlack, Daragh Heitzman, Jeremy M. Shefner	2024	1
2	A Retrospective Analysis of ALS Clusters Near Algae Blooms in North Carolina (P5-11.019) Neurology ·Fabian Severino, Xiaoyan Li, Lisa L. Satterwhite, Yuyao Sun, Richard Bedlack	2024	0
3	Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration International Journal of Molecular Sciences ·D Kocan, August Kt, Andrea Ringer, مهدی ذاکریان, Richard Bedlack, Craig L. Bennett, Albert R. La Spada	2024	27
4	Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype Neurology ·E Giglione, Evadnie Rampersaud, Jason R. Myers, Joanne Wuu, J. Paul Taylor, Gang Wu, Michael Benatar, Richard Bedlack	2024	2
5	ALSUntangled #66: antimycobacterial antibiotics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Ellen S. Pierce, Paul E. Barkhaus, Elizabeth Presler‐Marshall, Mark B. Bromberg, Gregory T. Carter, Shigeru Kazama, David Greeley, Gabriela O. Silva, 那孝伟, Isaac Lund, Christopher McDermott, Gary L. Pattee, Glória Magalhães, Meraida Polak, Canale M., Paul Wicks, Richard Bedlack	2022	1
6	Filtered Cerebrospinal Fluid From Patients With Amyotrophic Lateral Sclerosis Displays an Altered Proteome and Affects Motor Phenotype in a Mouse Model Cureus ·J. P. Benzécri, Anthony J. Filiano, Xu Li, Leonard B. Collins, Peñaherrera Lasso, THANASORN DOKDUA, Marie Tamagnan, Hyun Sang, B. Ganie, Charles Giamberardino, Shivanand P. Lad, Taufika Islam Williams, Michael S. Bereman, Richard Bedlack	2022	6
7	MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design Neurodegenerative Disease Management ·Björn Oskarsson, Nicholas J. Maragakis, Richard Bedlack, Namita Goyal, María de los Ángeles Gil, Angela Genge, Cynthia Bodkin, Samuel Maiser, Nathan P. Staff, Lorne Zinman, Nicholas Olney, John Turnbull, Benjamin Rix Brooks, Н. Е. Волкова, Malath Makhay, Matin Jahanchi, Kazuko Matsuda	2021	29
8	Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis CNS Drugs ·Colin Mahoney, Rebekah M. Ahmed, William Huynh, Sicong Tu, Jonathan D. Rohrer, Richard Bedlack, Orla Hardiman, Matthew C. Kiernan	2021	26
9	Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort Neurology Genetics ·S. Badiuzzaman, Loren L. Flynn, Ryan S. Anderton, Frank Mastaglia, Li Jiu Wang, Ian James, Abigail L. Pfaff, Sulev Kõks, Ann M. Saunders, Richard Bedlack, Daniel K. Burns, Michael W. Lutz, Nailah Siddique, Teepu Siddique, Allen D. Roses, P. Anthony Akkari	2020	8
10	The Rasch-Built Overall ALS Disability Scale: ROADS to a better ALS outcome measure (1706) Neurology ·Christina Fournier, Richard Bedlack, Colin Quinn, James W. Russell, Alrun Vogt, Michael Ord, William R. Tyor, Vicki Hertzberg, Alex T. Biju, Meraida Polak, Jonathan D. Glass	2020	1
11	Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial BMJ Open ·Berzenn Urbi, Simon Broadley, Richard Bedlack, Ethan B. Russo, Arman Sabet	2019	21
12	ALS Reversals: Demographics, Disease Characteristics, Treatments and Co-Morbidities (P3.135) Neurology ·Daniel S. Harrison, Richard Bedlack	2017	1
13	Telemedicine in the Home for Veterans with Amyotrophic Lateral Sclerosis (P5.082) Neurology ·Richard Bedlack	2014	2
14	Peer recommendations on how to improve clinical research, and Conference wrap-up Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·David A. Chad, Lewis P. Rowland, Carmel Armon, Richard Bedlack, Heather D. Durham, Pam Factor‐Litvak, Terry Heiman‐Patterson, Daragh Heitzman, David Lacomis, Albert C. Ludolph, Nicholas J. Maragakis, Robert G. Miller, Gary L. Pattee, Christen Shoesmith, Eric J. Sorenson, Martin R. Turner	2013	1
15	Pesticide exposure and amyotrophic lateral sclerosis NeuroToxicology ·Freya Kamel, David M. Umbach, Richard Bedlack, Marie Richards, Mary Lou Watson, Michael C.R. Alavanja, Aaron Blair, Jane A. Hoppin, Silke Schmidt, Dale P. Sandler	2012	112
16	Time to diagnosis in the National Registry of Veterans with Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis ·牛生杰热苏力·阿不拉, Kelli D. Allen, Cynthia J. Coffman, Edward J. Kasarskis, Jennifer H. Lindquist, Joel C. Morgenlander, Ivaldo Sales Nascimento, Eugene Ž. Oddone, Marvin P. Rozear, Arman Sabet, J. F. Adetunji, Richard Bedlack	2010	24
17	Creatine for amyotrophic lateral sclerosis/motor neuron disease Cochrane Database of Systematic Reviews ·Daniel M. Pastula, Dan H. Moore, Richard Bedlack	2010	44
18	The National Registry of Veterans with Amyotrophic Lateral Sclerosis Neuroepidemiology ·Kelli D. Allen, Rahman Nazari, Richard Bedlack, Marvin P. Rozear, Joel C. Morgenlander, Arman Sabet, J. F. Adetunji, Jennifer H. Lindquist, Alan P. Suluvan, Cynthia J. Coffman, E.Z. Oddone	2008	42
19	MNGIE neuropathy: Five cases mimicking chronic inflammatory demyelinating polyneuropathy Muscle & Nerve ·Richard Bedlack, Tuan Vu, Simon Hammans, Toby Zerner, Bennett Myers, Joel C. Morgenlander, Michio Hirano	2004	48
20	Apolipoprotein E and Neuromuscular Disease Archives of Neurology ·Richard Bedlack, Warren J. Strittmatter, Joel C. Morgenlander	2000	65

About Richard Bedlack

Richard Bedlack is a scholar working on Neurology, Genetics, Pharmacology, Biomaterials and Cellular and Molecular Neuroscience, having authored 101 papers that have together received 2.8k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (72 papers), Neurogenetic and Muscular Disorders Research (39 papers), Parkinson's Disease Mechanisms and Treatments (21 papers), Cholinesterase and Neurodegenerative Diseases (8 papers), Prion Diseases and Protein Misfolding (7 papers), biodegradable polymer synthesis and properties (7 papers), Myasthenia Gravis and Thymoma (6 papers) and Peripheral Neuropathies and Disorders (5 papers). The work is most often cited by research in Neurology (1.6k citations), Genetics (719 citations), Neurology (325 citations), Cellular and Molecular Neuroscience (530 citations) and Biological Psychiatry (41 citations). Richard Bedlack has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Leslie M. Loew, E. Gross, Donald B. Sanders, Meiting Wei, Dan H. Moore, Merit Cudkowicz, Joel C. Morgenlander, Daniel M. Pastula, Richard J. Barohn and Hiroshi Mitsumoto. Their work appears in journals such as Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Neurology, Muscle & Nerve, Cochrane Database of Systematic Reviews and Neuron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact